In vitro peptide release from liquid crystalline buccal delivery systems.
Swelling and [D-Ala(2), D-Leu(5)]enkephalin (DADLE) release from the lamellar and cubic liquid crystalline phases of glyceryl monooleate (GMO) were studied using two in vitro methods, a total immersion method and a Franz cell method. The swelling of the lamellar phase and glyceryl monooleate (0% w/w water content) and DADLE release from the liquid crystalline phases were temperature dependent. The swelling ratio was greater at 20 degrees C than 37 degrees C while DADLE release increased at 37 degrees C compared to 20 degrees C for both the lamellar and cubic phases. The water uptake increased dramatically with decreasing initial water content of the liquid crystalline phases. However, DADLE release increased with increasing initial water content, which corresponded to increased viscosity. The swelling and DADLE release profiles obtained using a Franz cell method with a moist nylon membrane to mimic buccal drug release conditions were slower than the total immersion method. These results show that the swelling and DADLE release strongly depended on temperature, the initial water content of the liquid crystalline matrix and the methodology employed for determining the swelling and DADLE release.
Lee
J
J
Welsh School of Pharmacy, Cardiff University, Cardiff, UK.
Kellaway
I W
IW
D000278:Administration, Buccal; D003460:Crystallization; D016503:Drug Delivery Systems; D016308:Enkephalin, Leucine-2-Alanine / Q000008:administration & dosage / Q000737:chemistry*; D005989:Glycerides / Q000737:chemistry*; D006358:Hot Temperature; D013678:Technology, Pharmaceutical
D005989:Glycerides; D016308:Enkephalin, Leucine-2-Alanine; C005953:monoolein